 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

In trading on Thursday, shares of Axonics Inc (AXNX) crossed below their 200 day moving average of 56.76, changing hands as low as 55.41 per share. Axonics Inc shares are currently trading...

Axonics Breaks Below 200-Day Moving Average - Notable for AXNX

Axonics, Inc. (NASDAQ:AXNX  Get Free Report) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 3,090,000 shares, a growth of 7.7% from...

Axonics, Inc. (NASDAQ:AXNX) Short Interest Up 7.7% in August

This is a Bullish indicator signaling AXNX's price could rise from here. Traders may explore going long the stock or buying call options...

Axonics (AXNX, $61.29) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 11, 2023

First Light Asset Management LLC decreased its holdings in Axonics, Inc. (NASDAQ:AXNX  Free Report) by 0.4% in the 1st quarter, HoldingsChannel reports. The firm owned 309,240 shares of the...

Axonics, Inc. (NASDAQ:AXNX) Stock Position Lessened by First Light Asset Management LLC

Unveiling the True Worth of Axonics (AXNX)Related Stocks: AXNX...

Axonics (AXNX): A Significantly Undervalued Gem in the Medical Technology Sector?

This is a signal that AXNX's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Axonics (AXNX, $58.13) Stochastic Oscillator left the overbought zone on September 08, 2023

This indicator may be signaling AXNX's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Axonics (AXNX, $58.19) entered Uptrend as Momentum indicator ascends above 0 level on Sep 06, 2023

Axonics, Inc. (NASDAQ:AXNX  Get Free Report) was the recipient of a large drop in short interest in the month of August. As of August 15th, there was short interest totalling 2,870,000 shares, a drop of 18.0% from the July 31st total of 3,500,000 shares. Based on an average daily trading ...

Short Interest in Axonics, Inc. (NASDAQ:AXNX) Drops By 18.0%

Industrial Alliance Investment Management Inc. acquired a new stake in Axonics, Inc. (NASDAQ:AXNX  Free Report) in the first quarter, according to the company in its most recent Form 13F...

Industrial Alliance Investment Management Inc. Makes New Investment in Axonics, Inc. (NASDAQ:AXNX)

Axonics, Inc. (NASDAQ:AXNX Get Free Report) has received a consensus rating of Moderate Buy from the eleven brokerages that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and ten have issued a buy recommendation on the ...

Axonics, Inc. (NASDAQ:AXNX) Receives $76.36 Consensus PT from Analysts

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. The company was founded by Raymond W. Cohen, Guang Qiang Jiang, and Danny L. Dearen in March 2012 and is headquartered in Irvine, CA.

Watchers	595
52-Wk Low	$47.59
52-Wk High	$77.20

Market Cap	$2.88B
Volume (M)	39,664.00
52-Wk High	$77.20
52-Wk Low	$47.59

AXNX Axonics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals